Healthcare Industry News: Innovative Spinal Technologies
News Release - September 27, 2006
Innovative Spinal Technologies Names Frederic Moll, M.D., to Board of DirectorsMANSFIELD, Mass., Sept. 27 (HSMN NewsFeed) -- Innovative Spinal Technologies, Inc. (IST), quickly emerging as a leading developer of the world's most advanced minimally invasive treatments for spinal disorders, announced the appointment of Frederic Moll, M.D., to the company's Board of Directors.
"Dr. Moll brings an incredible wealth of knowledge and seasoned judgment to IST," said Scott Schorer, President and CEO of IST. "Fred is a terrific addition and I'm delighted to have him join our Board of Directors. Fred's track record as an entrepreneur who delivers outstanding clinical innovation will be of great value to our shareholders."
"Scott and his team have done an incredible job in assembling one of the best teams in the spine industry," commented Frederic Moll, M.D., who is the current founder and CEO of Hansen Medical. "The company's suite of breakthrough technologies offers great potential. I couldn't be more pleased to join IST."
Frederic Moll, M.D., founded Hansen Medical in 2002, and currently serves as President and CEO, bringing with him more than 20 years of medical device and high technology experience. In 1995, Dr. Moll founded Intuitive Surgical Inc., and served as the company's first CEO. Intuitive Surgical is the world leader in surgical robotics and is a publicly traded company. Prior to Intuitive Surgical, Dr. Moll co-founded Origin Medsystems, Inc., which became an operating company within Guidant Corporation following the acquisition by Eli Lilly in 1992. Dr. Moll served as medical director of Guidant's surgical device division from 1992-1995. Before co-founding Origin Medsystems, Dr. Moll invented the safety trocar, which fostered in modern general laparoscopic surgery; he also founded Endotherapeutics, which was acquired by U.S. Surgical in 1992.
About IST: Innovative Spinal Technologies, Inc.
Headquartered in Mansfield, Mass., and founded in 2002, IST is a privately held spine technology company committed to advancing patient treatment by developing the world's most advanced products focused on minimally invasive fusion and motion preservation. IST is a rapidly growing company, and leverages a strong investor group consisting of MPM Capital, Orbimed Advisors, and Panorama Capital. IST's partners include some of the world's most advanced clinical leaders. More information about IST can be found at www.istspine.com
Source: Innovative Spinal Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.